Cargando…
Validation of the Liver Disease Quality of Life Instrument 1.0 in Patients with Chronic Hepatitis B: A Prospective Study
The purpose of this study was to report on the clinical usefulness of the Liver Disease Quality of Life Instrument (LDQOL) 1.0, which was prospectively measured in chronic hepatitis B patients. We regularly followed up with patients with chronic hepatitis B between 2008 and 2010 who were enrolled in...
Autores principales: | Ha, Yeonjung, Hwang, Sohyun, Chon, Young Eun, Kim, Mi Na, Lee, Joo Ho, Hwang, Seong Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572606/ https://www.ncbi.nlm.nih.gov/pubmed/31083480 http://dx.doi.org/10.3390/jcm8050656 |
Ejemplares similares
-
Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
por: Ha, Yeonjung, et al.
Publicado: (2020) -
Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
por: Lim, Jihye, et al.
Publicado: (2021) -
Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
por: Cho, Heejin, et al.
Publicado: (2023) -
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
por: Lee, Yun Bin, et al.
Publicado: (2019) -
Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease
por: Chon, Young Eun, et al.
Publicado: (2020)